Using the nation's largest COVID-19 data resource, a researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center found the COVID-19 vaccine protected most cancer patients from getting COVID. However, ...
Apr 4, 2022
0
62
Matching cancer patients to treatment based on their levels of a key immune protein may allow doctors to select those who would benefit most from the combination of immunotherapy and chemotherapy, researchers report.
Mar 28, 2022
0
71
Men with microscopic evidence of prostate cancer spreading to their pelvic lymph nodes (LNs) following the surgical resection of the prostate and pelvic lymph nodes (LN) are at a very high risk of dying from prostate cancer. ...
Mar 15, 2022
0
3
Adding the proteasome inhibitor bortezomib to chemotherapy significantly improved overall survival in children and young adults with newly diagnosed T-cell lymphoblastic lymphoma (T-LL), according to a Children's Oncology ...
Mar 10, 2022
0
63
In cancer, there's a mistake in the hereditary material, the DNA, which causes uncontrollable growth of cells in the body. One in ten children with cancer has hereditary predisposition: a combination of DNA changes, spontaneous ...
Mar 1, 2022
0
2
(HealthDay)—Gender differences extend to cancer treatments, with women having a higher risk of severe side effects from certain treatments than men, a new study finds.
Feb 15, 2022
0
11
A detailed analysis by researchers at UNC Lineberger Comprehensive Cancer Center and Greensboro Health Disparities Collaborative designed to address racial inequities in timing from diagnosis to surgery for lung cancer has ...
Feb 14, 2022
0
2
An online symptom management tool that harnesses the problem-solving benefits of expressive writing could help women with ovarian cancer better manage complex symptoms, according to a new study led by a University of Pittsburgh ...
Feb 7, 2022
0
4
An experimental form of immunotherapy that uses an individual's own tumor-fighting immune cells could potentially be used to treat people with metastatic breast cancer, according to results from an ongoing clinical trial ...
Feb 1, 2022
0
95
(HealthDay)—A polygenic score derived from pharmacogenomic evaluation of cytarabine (ara-C) pathway can help personalize treatment for pediatric patients with acute myeloid leukemia (AML), according to a study published ...
Feb 1, 2022
0
5
